E-LIB Suche - Ergebnisse für: Voskoboynik, M

1

44P Exploratory analysis of peripheral pharmacodynamic (PD)..:

Wu, Y-L. ; Gao, B. ; Goh, J.C....
Immuno-Oncology and Technology. 20 (2023) - p. 100512 , 2023

Link: https://doi.org/10.1016/..

2

First-in-human phase 1 study of the anti-TIGIT antibody vib..:

Niu, J. ; Maurice-Dror, C. ; Lee, D.H....
Annals of Oncology. 33 (2022) 2 - p. 169-180 , 2022

Link: https://doi.org/10.1016/..

3

Stereotactic Radiotherapy Combined with Immunotherapy Is Sa..:

Ratnayake, G. ; Reinwald, S. ; Shackleton, M....
International Journal of Radiation Oncology*Biology*Physics. 105 (2019) 1 - p. S61 , 2019

Link: https://doi.org/10.1016/..

4

A phase I dose escalation, safety and pharmacokinetic (PK) ..:

Chowdhury, S. ; Burris III, H.A. ; Patel, M....
European Journal of Cancer. 69 (2016) - p. S145 , 2016

Link: https://doi.org/10.1016/..

5

27LBA Evidence of activity of a new mechanism of action (Mo..:

Arkenau, H.T. ; Voskoboynik, M. ; Infante, J....
European Journal of Cancer. 51 (2015) - p. S724 , 2015

Link: https://doi.org/10.1016/..

6

High‐dose chemotherapy with autologous stem cell transplant..:

Lewin, J. ; Dickinson, M. ; Voskoboynik, M....
Internal Medicine Journal. 44 (2014) 8 - p. 771-778 , 2014

Link: https://doi.org/10.1111/..

7

Autoimmune hypophysitis in a patient successfully treated w..:

Sutton, R.A. ; Voskoboynik, M. ; McArthur, G.A..
Pathology. 45 (2013) - p. S84 , 2013

Link: https://doi.org/10.1097/..

8

The coloniality of green extractivism: Unearthing decarboni..:

Andreucci, Diego ; García López, Gustavo ; Radhuber, Isabella M....
Political Geography. 107 (2023) - p. 102997 , 2023

Link: https://doi.org/10.1016/..

9

A First-in-Human Dose Finding Study of Camrelizumab in Pati..:

Lickliter JD ; Gan HK ; Voskoboynik M...
https://www.dovepress.com/a-first-in-human-dose-finding-study-of-camrelizumab-in-patients-with-a-peer-reviewed-article-DDDT. , 2020

Link: https://doaj.org/article..

10

A First-in-Human Dose Finding Study of Camrelizumab in Pati..:

Lickliter, JD ; Gan, HK ; Voskoboynik, M...
issn:1177-8881. , 2020

Link: http://hdl.handle.net/11..

11

Prospective analysis of 895 patients on a UK Genomics Revie..:

Moore, DA ; Kushnir, M ; Mak, G...
https://discovery.ucl.ac.uk/id/eprint/10071932/7/Forster%20_Prospective%20analysis%20of%20895%20patients%20on%20a%20UK%20Genomics%20Review%20Board_VoR%20%281%29.pdf. , 2019

Link: https://discovery.ucl.ac..

12

An update on adjuvant systemic therapies in melanoma:

Samuel, E ; Moore, M ; Voskoboynik, M..
issn:2045-0885. , 2019

Link: http://hdl.handle.net/11..

13

SELECT-3: a phase I study of selumetinib in combination wit..:

Greystoke, A ; Steele, N ; Arkenau, H-T...
https://discovery.ucl.ac.uk/id/eprint/10050852/1/Greystoke_Select-3.pdf. , 2017

Link: https://discovery.ucl.ac..

14

SELECT-3: a phase I study of selumetinib in combination wit..:

Dean, Emma ; Steele, Nicola ; Arkenau, Hendrik-Tobias...
Dean , E , Steele , N , Arkenau , H-T , Blackhall , F , Lindsay , C , Saggese , M , Califano , R , Greystoke , A , Voskoboynik , M , Ghiorghiu , D , Dymond , A , Smith , I & Plummer , R 2017 , ' SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting. ' , British Journal of Cancer , pp. 938-946 . https://doi.org/10.1038/bjc.2017.271. , 2017

Link: https://research.manches..

15

Malignancy risk and mortality after lung transplantation: A..:

Yeoh, Hui-Ling ; Shingles, Helen ; Paul, Eldho...
JHLT Open. 4 (2024) - p. 100094 , 2024

Link: https://doi.org/10.1016/..